skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Late effects of Hodgkin lymphoma treatment
ISBN: 9789464198706 ;ISBN: 9464198702 ;DOI: 10.5463/thesis.315
Digital Resources/Online E-Resources
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Late effects of Hodgkin lymphoma treatment
Author:
de Vries, Simone
Subjects:
cardiovascular disease
;
hart- en vaatziekten
;
Hodgkin lymphoma
;
Hodgkinlymfoom
;
late effecten
;
late effects
;
risicopredictie
;
risk prediction
;
second malignant neoplasms
;
tweede tumoren
Description:
Hodgkin lymphoma (HL) is one of the most commonly diagnosed malignancies among adolescents and young adults and has become a prototype of a curable malignancy because of improvements in combined modality treatment over the past decades. Currently, cure rates are exceeding 90% for patients with early-stage disease and approaching the same level in patients with advanced disease. However, both radiotherapy and chemotherapy for the treatment of HL are associated with late adverse effects, of which second malignant neoplasms (SMN) and cardiovascular disease (CVD) are the most serious. The general aim of this thesis was to evaluate late effects associated with treatment for HL. In chapter 2 we examined the combined burden from SMN and CVD after treatment for HL. After a median follow-up of 22 years, we identified 888 SMNs and 1,153 CVDs in 1,247 patients. At 40 years after treatment for HL, the cumulative incidence for developing either SMN or CVD was 68% and the cumulative incidence for developing both SMN and CVD was 17%. We observed that radiotherapy was the strongest risk factor for developing both SMN and CVD in multivariable Cox regression models. Treating physicians should be aware of the increased risk of developing both SMNs and CVD in patients treated for HL until 2000. In chapter 3, we assessed breast cancer risk in male 5-year HL survivors. After a median follow-up of 20 years, we observed eight cases of male breast cancer. Male HL survivors experienced a 23-fold increased breast cancer risk compared to general population rates, representing 1.6 excess breast cancers per 10,000 person-years. The overall cumulative breast cancer incidences at 20 and 40 years after HL treatment were 0.1%, and 0.7%, respectively. To ensure early diagnosis and treatment, clinicians should be alert to symptoms of breast cancer in male survivors of HL. In chapter 4 we compared causes of death derived from medical records (CODMR) with causes of death derived from death certificates (CODDC), as processed by Statistics Netherlands, of patients primarily treated for HL or breast cancer. Overall, we observed high levels of agreement between CODMR and CODDC for common causes of death in HL (81%) and breast cancer patients (97%). Observed discrepancies between CODMR and CODDC frequently occurred in the presence of potential late effects of treatment for HL. In chapter 5 we examined long-term cause-specific excess mortality after HL treatment. Whereas HL mortality statistically significantly decreased over calendar period of treatment, solid tumor mortality did not change in the most recent treatment era (1989-2000). We also observed that infectious disease mortality was not only increased after splenectomy but also after spleen irradiation. Compared with the general population, HL survivors have a substantially reduced life expectancy. Therefore, optimal selection of patients for primary chemotherapy is crucial, weighing risks of HL relapse against long-term toxicity. In chapter 6 we aimed to develop prediction models for risk of coronary heart disease and heart failure for HL survivors treated in adolescence and (early) adulthood. We were able to predict coronary heart disease and heart failure risk at 20 and 30 years after treatment with moderate to good overall calibration and moderate discrimination (areas under the curve: 0.68-0.74), which was confirmed by external validation for the coronary heart disease model (areas under the curve: 0.73-0.74). On the basis of our model including prescribed mediastinal radiation dose, 30-year risks ranged from 4% to 78% for coronary heart disease and 3% to 46% for heart failure, depending on risk factors. These models can be used to identify HL survivors who might benefit from targeted screening for CVD and early treatment for CVD risk factors in survivorship care.
Creation Date:
2023
Language:
English
Identifier:
ISBN: 9789464198706
ISBN: 9464198702
DOI: 10.5463/thesis.315
Source:
Vrije Universiteit
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript